Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

The Mount Sinai Journal of Medicine, New York
Dara L DicksteinPatrick R Hof

Abstract

Recent findings indicate that vascular risk factors and neurovascular dysfunction play integral roles in the pathogenesis of Alzheimer's disease. In addition to aging, the most common risk factors for Alzheimer's disease are apolipoprotein e4 allele, hypertension, hypotension, diabetes, and hypercholesterolemia. All of these can be characterized by vascular pathology attributed to conditions such as cerebral amyloid angiopathy and subsequent blood-brain barrier dysfunction. Many epidemiological, clinical, and pharmacotherapeutic studies have assessed the associations between such risk factors and Alzheimer's disease and have found positive associations between hypertension, hypotension, and diabetes mellitus. However, there are still many conflicting results from these population-based studies, and they should be interpreted carefully. Recognition of these factors and the mechanisms by which they contribute to Alzheimer's disease will be beneficial in the current treatment regimens for Alzheimer's disease and in the development of future therapies. Here we discuss vascular factors with respect to Alzheimer's disease and dementia and review the factors that give rise to vascular dysfunction and contribute to Alzheimer's disease.

References

Feb 15, 1992·American Journal of Epidemiology·L E HebertD A Evans
Jan 1, 1992·Journal of Neuroscience Research·A NordbergB Winblad
Jun 22, 1991·BMJ : British Medical Journal·C M van Duijn, A Hofman
Apr 1, 1990·Journal of the Neurological Sciences·T del SerJ Constantinidis
Mar 25, 1989·BMJ : British Medical Journal·R Shinton, G Beevers
Jul 1, 1989·Acta Neurologica Scandinavica·V Di PieroC Fieschi
Mar 26, 1988·British Medical Journal·K MattilaR Heikinheimo
Jun 1, 1988·American Journal of Public Health·A L DannenbergW B Kannel
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Mar 1, 1988·Journal of the American Geriatrics Society·G P Wolf-KleinJ Breuer
Sep 1, 1970·Journal of the Neurological Sciences·B E TomlinsonM Roth
Aug 1, 1995·Journal of the Neurological Sciences·D L SparksJ C Hunsaker
Jun 1, 1994·Journal of the Autonomic Nervous System·W J BurkeH D Chung
Sep 15, 1993·American Journal of Epidemiology·M F EliasL R White
Mar 30, 1996·BMJ : British Medical Journal·Z GuoB Winblad
Apr 27, 1996·Lancet·I SkoogA Svanborg
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Feb 23, 1996·The Journal of Biological Chemistry·S Bodovitz, W L Klein
Aug 1, 1996·Journal of the American Geriatrics Society·K A NielsonC W Cotman
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·K Johnson-WoodL McConlogue
Mar 12, 1997·JAMA : the Journal of the American Medical Association·A J SlooterR Mayeux
Feb 15, 1997·American Journal of Epidemiology·C L LeibsonP J Palumbo
Jul 9, 1997·JAMA : the Journal of the American Medical Association·G C Roman
Nov 5, 1997·Annals of the New York Academy of Sciences·C L LeibsonP J Palumbo

❮ Previous
Next ❯

Citations

Jun 19, 2012·Translational Stroke Research·Mark FisherDavid H Cribbs
Nov 22, 2012·Clinical and Experimental Pharmacology & Physiology·Ryusuke TakechiJohn C Mamo
Aug 26, 2011·Dementia and Geriatric Cognitive Disorders·Sid E O'BryantUNKNOWN Texas Alzheimer’s Research and Care Consortium
Sep 18, 2012·Lipids in Health and Disease·Menuka Pallebage-GamarallageJohn Mamo
Jan 5, 2011·PloS One·Brian P HeadHemal H Patel
Oct 31, 2012·Vascular Health and Risk Management·Alex E RoherThomas G Beach
May 12, 2011·International Journal of Alzheimer's Disease·Valérie LeducJudes Poirier
Jun 23, 2012·Future Neurology·Helen E Scharfman
Jun 19, 2012·Neurología : publicación oficial de la Sociedad Española de Neurología·J Campdelacreu
Feb 11, 2012·Acta neurochirurgica·Zandra Olivecrona, Lars-Owe D Koskinen
Mar 6, 2016·Journal of the Neurological Sciences·Omar ŠerýVladimir J Balcar
Dec 19, 2015·Critical Reviews in Clinical Laboratory Sciences·Menuka Pallebage-GamarallageJohn Mamo
Jan 23, 2016·Frontiers in Aging Neuroscience·Noelia CalvoAgustín Ibáñez
Oct 25, 2011·Archives of Gerontology and Geriatrics·Yusuf YesilServet Ariogul
Jan 5, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jennifer Palmer, Seth Love
Sep 30, 2010·Journal of the Neurological Sciences·Deborah R Gustafson
Apr 4, 2015·Disease Markers·JaeHoon JungDoHoon Kim
Jul 17, 2010·The British Journal of Dermatology·K AbuabaraJ M Gelfand
Nov 4, 2010·Journal of Neuroscience Research·Brian Jeynes, John Provias
Nov 22, 2011·The Journal of Comparative Neurology·Alan Peters, Claire Sethares
Dec 9, 2014·European Journal of Nutrition·Antonia TrichopoulouPagona Lagiou
Feb 3, 2015·The Journal of Physiology·Douglas R SealsThomas J LaRocca
Nov 4, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Tyler A KokjohnAlex E Roher
Jul 19, 2011·Neurobiology of Aging·Leonidas ChouliarasBart P F Rutten
May 23, 2015·The British Journal of Nutrition·W M A D B FernandoR N Martins
Feb 19, 2011·Translational Neuroscience·Elizabeth SchwartzPatrick R Hof
Sep 3, 2013·Biochimica Et Biophysica Acta·Ana Catarina R G FonsecaCláudia F Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.